Your browser doesn't support javascript.
Guillain-Barré syndrome decreases in Singapore during the COVID-19 pandemic.
Umapathi, Thirugnanam; Er, Benjamin; Koh, Jasmine Shimin; Goh, Yi Hui; Chua, Lily.
  • Umapathi T; National Neuroscience Institute, Singapore.
  • Er B; Epidemiology and Disease Control Division, Ministry of Health, Singapore.
  • Koh JS; National Neuroscience Institute, Singapore.
  • Goh YH; Department of Neurology, National University Health Systems, Singapore.
  • Chua L; Epidemiology and Disease Control Division, Ministry of Health, Singapore.
J Peripher Nerv Syst ; 26(2): 235-236, 2021 06.
Article in English | MEDLINE | ID: covidwho-1132986
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: J Peripher Nerv Syst Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: Jns.12439

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Asia Language: English Journal: J Peripher Nerv Syst Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: Jns.12439